Some of the current studies have shown that USP14 shows a positive correlation with liver disease development by regulating several metabolism-related signaling molecules, including hypoxia-inducible factor [14], cAMP-response element binding protein [15], and fatty acid synthase (FASN) [16], to promote tumor proliferation, survival, and liver IR. This evidence concerns the gene FASN and liver disorder.